About Mepsgen
Mepsgen is a company based in Seoul (South Korea) founded in 2019 by Yongtae Kim.. Mepsgen has raised $29.26 million across 4 funding rounds from investors including Korean Development Bank, Yuanda Financial Holdings and KB Investment. Mepsgen offers products and services including MEPS-X, MST-X, and NanoCalibur. Mepsgen operates in a competitive market with competitors including Emulate, CN Bio, AxoSim, Mimetas and Nortis, among others.
- Headquarter Seoul, South Korea
- Founders Yongtae Kim
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Mepsgen Co., Ltd.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$29.26 M (USD)
in 4 rounds
-
Latest Funding Round
$14.84 M (USD), Series C
Nov 19, 2024
-
Investors
Korean Development Bank
& 6 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Mepsgen
Mepsgen offers a comprehensive portfolio of products and services, including MEPS-X, MST-X, and NanoCalibur. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Automated platform for modeling human tissue barriers in drug testing
Tools for scalable production of lipid nanoparticles
Automated system for nanoparticle manufacturing from lab to GMP scale
Funding Insights of Mepsgen
Mepsgen has successfully raised a total of $29.26M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $14.84 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series C — $14.8M
-
First Round
First Round
(01 Aug 2020)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2024 | Amount | Series C - Mepsgen | Valuation | Yuanda Financial Holdings , KB Investment | |
| Jul, 2022 | Amount | Series B - Mepsgen | Valuation |
investors |
|
| Aug, 2021 | Amount | Series A - Mepsgen | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Mepsgen
Mepsgen has secured backing from 7 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Korean Development Bank, Yuanda Financial Holdings and KB Investment. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund investing in early-stage tech startups
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Sector-agnostic VC firm investing in geographies such as South Korea
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Mepsgen
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Mepsgen
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Mepsgen Comparisons
Competitors of Mepsgen
Mepsgen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Emulate, CN Bio, AxoSim, Mimetas and Nortis, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of in vitro models for drug development
|
|
| domain | founded_year | HQ Location |
Organ-on-a-chip platforms are developed for drug discovery applications.
|
|
| domain | founded_year | HQ Location |
Nerve-on-a-chip technology is advanced by AxoSim for drug development improvement.
|
|
| domain | founded_year | HQ Location |
Microfluidics-based organ-on-a-chip models for drug evaluation are developed.
|
|
| domain | founded_year | HQ Location |
Small human tissue segments are generated in microfluidic chips.
|
|
| domain | founded_year | HQ Location |
Microfluidic devices are developed for industrial applications and brain-on-a-chip models.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Mepsgen
When was Mepsgen founded?
Mepsgen was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Where is Mepsgen located?
Mepsgen is headquartered in Seoul, South Korea.
Who is the current CEO of Mepsgen?
Yongtae Kim is the current CEO of Mepsgen. They have also founded this company.
Is Mepsgen a funded company?
Mepsgen is a funded company, having raised a total of $29.26M across 4 funding rounds to date. The company's 1st funding round was a Series A of $3.47M, raised on Aug 01, 2020.
What does Mepsgen do?
Developer of human organ model chips for pharmaceutical development. The company develops and produces a 3D cell cultures organ-on-a-chip platform such as the MEPS-X series and MG-X series to develop drug candidates which target Alzheimers and brain tumors.
Who are the top competitors of Mepsgen?
Mepsgen's top competitors include Emulate, CN Bio and Cellbox Labs.
What products or services does Mepsgen offer?
Mepsgen offers MEPS-X, MST-X, and NanoCalibur.
Who are Mepsgen's investors?
Mepsgen has 7 investors. Key investors include Korean Development Bank, Yuanda Financial Holdings, KB Investment, SBI Investment Korea, and Live Cell Instrument.